Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Treasury Shares (2020 - 2023)

RAPT Therapeutics (RAPT) has disclosed Treasury Shares for 4 consecutive years, with $13500.0 as the latest value for Q4 2023.

  • Quarterly Treasury Shares fell 50.0% to $13500.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $13500.0 through Dec 2023, down 50.0% year-over-year, with the annual reading at $13500.0 for FY2023, 50.0% down from the prior year.
  • Treasury Shares hit $13500.0 in Q4 2023 for RAPT Therapeutics, roughly flat from $13500.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $56500.0 in Q2 2020 to a low of $13500.0 in Q1 2023.
  • Historically, Treasury Shares has averaged $32900.0 across 4 years, with a median of $27000.0 in 2022.
  • Biggest five-year swings in Treasury Shares: dropped 28.32% in 2021 and later crashed 50.0% in 2023.
  • Year by year, Treasury Shares stood at $56500.0 in 2020, then decreased by 28.32% to $40500.0 in 2021, then crashed by 33.33% to $27000.0 in 2022, then plummeted by 50.0% to $13500.0 in 2023.
  • Business Quant data shows Treasury Shares for RAPT at $13500.0 in Q4 2023, $13500.0 in Q3 2023, and $13500.0 in Q2 2023.